GlassScriptPhysician profile
Neethu Mathew
NPI 1528355906
$1,408.10
in general payments reported to CMS, 2019-2025
25 companies · $229 in 2025
The $229 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $71.29 · 2020: $83.74 · 2021: $405 · 2023: $371 · 2024: $248 · 2025: $229.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $848.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $847.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $343.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Medtronic, INC. | $194.98 | 2023 | Interstim |
| Lilly USA, LLC | $190.70 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Otsuka America Pharmaceutical, INC. | $95.42 | 2021 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $60.23 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $52.01 | 2021 | |
| Lundbeck LLC | $43.30 | 2021 | |
| Dexcom, INC. | $41.43 | 2024 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $39.06 | 2019-2024 | |
| Abbott Laboratories | $36.07 | 2021 | |
| Aimmune Therapeutics, INC. | $34.21 | 2025 | Zenpep |
| Janssen Pharmaceuticals, INC | $31.11 | 2019-2021 | |
| Glaxosmithkline, LLC. | $28.22 | 2023-2025 | Trelegy Ellipta |
| Alexion Pharmaceuticals, INC. | $24.64 | 2025 | Strensiq |
| Abbvie INC. | $22.80 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $20.36 | 2019 | |
| Grifols USA, LLC | $19.24 | 2024 | Prolastin-C Liquid |
| Nestle Healthcare Nutrition INC. | $18.46 | 2023 | |
| Exact Sciences Corporation | $17.62 | 2025 | Cologuard Collection Kit |
| Phathom Pharmaceuticals, INC. | $17.40 | 2025 | Voquezna |
| Amgen INC. | $16.75 | 2024 | Prolia, Evenity |
| Pfizer INC. | $16.54 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.41 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.39 | 2025 | |
| Lucid Diagnostics INC. | $13.19 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Neethu Mathew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.